Education
About Us
Working with TipRanks
Follow Us
Pfizer Inc (PFE)
:PFE
PFE Stock Chart & Stats
Day’s Range― - ―
52-Week Range$20.92 - $31.54
Previous CloseN/A
Volume12.20M
Average Volume (3M)63.85M
Market Cap
$135.72B
Enterprise Value$198.11B
Total Cash (Recent Filing)$2.18B
Total Debt (Recent Filing)$44.17B
Price to Earnings (P/E)17.3
Beta0.27
Next Earnings
Aug 05, 2025EPS Estimate
0.57Next Dividend Ex-Date
May 09, 2025Dividend Yield6.92%
Share Statistics
EPS (TTM)1.38
Shares Outstanding5,671,454,600
10 Day Avg. Volume48,979,755
30 Day Avg. Volume63,845,572
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.46
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.20
Enterprise Value/Ebitda10.93
Forecast
1Y Price Target
$27.69Price Target Upside15.71% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering18
---
Bulls Say, Bears Say
Bulls Say
Cost ManagementRobust expense management led to a significant bottom line beat, surpassing expectations by 37%.
DividendsCFO David Denton reassured investors that the company remains committed to maintaining and growing its dividend over time.
ValuationPfizer remains a cheap stock with a high dividend yield of over 7%, making it attractive to value investors.
Bears Say
Product PerformancePFE reported a Q1 topline miss primarily due to underperformance in products like Paxlovid, Eliquis, Padcev, and Adcetris.
Regulatory EnvironmentThe rapidly evolving political and economic environment poses challenges, particularly with potential sector-specific tariffs and regulatory changes.
Revenue GrowthThe longer-term outlook suggests that PFE does not anticipate strong revenue growth in the next 3 years due to loss of exclusivity on certain products.
---
Ownership Overview
0.03% Insiders
17.10% Mutual Funds
0.73% Other Institutional Investors
60.43% Public Companies and
Individual Investors
PFE FAQ
What was Pfizer Inc’s price range in the past 12 months?
Pfizer Inc lowest stock price was $20.91 and its highest was $31.54 in the past 12 months.
What is Pfizer Inc’s market cap?
Pfizer Inc’s market cap is $135.72B.
When is Pfizer Inc’s upcoming earnings report date?
Pfizer Inc’s upcoming earnings report date is Aug 05, 2025 which is in 94 days.
How were Pfizer Inc’s earnings last quarter?
Pfizer Inc released its earnings results on Apr 29, 2025. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.666 by $0.254.
Is Pfizer Inc overvalued?
According to Wall Street analysts Pfizer Inc’s price is currently Undervalued.
Does Pfizer Inc pay dividends?
Pfizer Inc pays a Quarterly dividend of $0.43 which represents an annual dividend yield of 6.92%. See more information on Pfizer Inc dividends here
What is Pfizer Inc’s EPS estimate?
Pfizer Inc’s EPS estimate is 0.57.
How many shares outstanding does Pfizer Inc have?
Pfizer Inc has 5,671,454,600 shares outstanding.
What happened to Pfizer Inc’s price movement after its last earnings report?
Pfizer Inc reported an EPS of $0.92 in its last earnings report, beating expectations of $0.666. Following the earnings report the stock price went up 3.21%.
Which hedge fund is a major shareholder of Pfizer Inc?
Currently, no hedge funds are holding shares in PFE
---
Pfizer Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$27.69 (15.71% Upside)
$27.69 (15.71% Upside)
Blogger Sentiment
Bullish
PFE Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 23.0M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $414.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days >0.1%
Last 30 Days ▲ 1.0%
Last 30 Days ▲ 1.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
1.25%
12-Months-Change
Fundamentals
Return on Equity
9.05%
Trailing 12-Months
Asset Growth
-5.79%
Trailing 12-Months
Company Description
Pfizer Inc
Pfizer Inc. is a leading global pharmaceutical corporation headquartered in New York City. It engages in the discovery, development, manufacture, and sale of healthcare products, with a focus on medicines and vaccines. Pfizer operates across multiple therapeutic areas, including oncology, immunology, cardiology, and neurology, and is known for its innovative research and development efforts, contributing to the advancement of healthcare worldwide.
---
PFE Company Deck
---
PFE Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Pfizer's earnings call highlighted a strong R&D pipeline and strategic focus on growth areas such as oncology and cardiometabolic segments, alongside significant growth in key products. However, the company also faced challenges, including a decline in overall revenue and potential impacts from global trade uncertainties and competition. Despite these challenges, Pfizer demonstrated strong operational efficiency and cost management, positioning itself for future growth.Read More>---
PFE Revenue Breakdown
47.36% Primary Care
26.17% Specialty Care
24.54% Oncology
1.80% PFIZER CENTREONE
0.13% PFIZER IGNITE
---
PFE Stock 12 Month Forecast
Average Price Target
$27.69
▲(15.71% Upside)
Technical Analysis
---